Colorectal cancer chemotherapy: Irinotecan

被引：0
|
作者：
Rougier, P [1 ]
Mitry, E [1 ]
机构：
[1] Hop Ambroise Pare, Dept GastroEnterol & Digest Oncol, F-92100 Boulogne, France
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 143
页数：6
相关论文
共 50 条
  • [41] Irinotecan for the treatment of metastatic colorectal cancer
    Assenat, Eric
    Duffour, Jacqueline
    Ychou, Marc
    BULLETIN DU CANCER, 2006, 93 (05) : 507 - 515
  • [42] The role of irinotecan in colorectal cancer.
    Saltz L.B.
    Current Oncology Reports, 1999, 1 (2) : 155 - 160
  • [43] COMBINATION CHEMOTHERAPY WITH BIWEEKLY CETUXIMAB AND IRINOTECAN FOR WILD-TYPE KRAS METASTATIC COLORECTAL CANCER, REFRACTORY TO BOTH OXALIPLATIN AND IRINOTECAN
    Barbosa, Caroline
    Sousa, Romulado
    Sabbaga, Jorge
    Cotti, Guilherme
    Saragiotto, Daniel
    Hoff, Paulo
    ANNALS OF ONCOLOGY, 2011, 22 : v103 - v103
  • [44] Optimizing irinotecan regimens for colorectal cancer
    Kein-Leong Yim
    David Cunningham
    Nature Reviews Clinical Oncology, 2009, 6 : 560 - 561
  • [45] Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progressionfree survival in patients with advanced and/or metastatic colorectal cancer
    Wulaningsih, Wahyu
    Wardhana, Ardyan
    Watkins, Johnathan
    Yoshuantari, Naomi
    Repana, Dimitra
    Van Hemelrijck, Mieke
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [46] Irinotecan and thalidomide in metastatic colorectal cancer
    Govindarajan, R
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 29 - 32
  • [47] Optimizing the use of irinotecan in colorectal cancer
    Cunningham, D
    Maroun, J
    Vanhoefer, U
    Van Cutsem, E
    ONCOLOGIST, 2001, 6 : 17 - 23
  • [48] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Hesketh, Paul J.
    Bosnjak, Snezana M.
    Nikolic, Vlada
    Rapoport, Bernardo
    SUPPORTIVE CARE IN CANCER, 2011, 19 (12) : 2063 - 2066
  • [49] Irinotecan plus raltitrexed as second-line chemotherapy for metastatic colorectal cancer: A retrospective study
    Lian, Jie
    Wang, Ren
    Wang, Xin
    Pang, Xiangyi
    Xu, Benjie
    Tang, Shuli
    Shao, Jiayue
    Lu, Haibo
    ONCOLOGY LETTERS, 2024, 28 (03)
  • [50] Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy
    Paul J. Hesketh
    Snezana M. Bosnjak
    Vlada Nikolic
    Bernardo Rapoport
    Supportive Care in Cancer, 2011, 19
12345